title: Rapid MB CK subform assay and the early diagnosis of myocardial infarction.
abstract: Seventy percent of patients admitted to coronary care units are ruled out for acute myocardial infarction. It has been estimated that 2-3 billion dollars each year could be saved if these non-AMI patients could be identified early, allowing the patient to be admitted to a less intensive setting. This study evaluated a new bedside device, the Cardiac STATus CK-MB/Myoglobin device for its utility in rapidly ruling out AMI. The device demonstrated a 99% negative predictive value within three hours of patient presentation.
authors.affiliation: Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: R
authors.initials: R
authors.lastname: Roberts
mesh_terms: D003402:Creatine Kinase / Q000097:blood*; D006801:Humans; D007527:Isoenzymes; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D009211:Myoglobin / Q000097:blood; D012680:Sensitivity and Specificity; D013997:Time Factors; D014336:Troponin / Q000097:blood
chemical_list: D007527:Isoenzymes; D009211:Myoglobin; D014336:Troponin; D003402:Creatine Kinase